DIPLOMAT PHARMACY INC's ticker is DPLO and the CUSIP is 25456K101. A total of 158 filers reported holding DIPLOMAT PHARMACY INC in Q1 2017. The put-call ratio across all filers is 1.05 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2017 | $362,000 | -6.7% | 24,430 | +0.5% | 0.01% | -9.1% |
Q1 2017 | $388,000 | +22.8% | 24,310 | -3.1% | 0.01% | +22.2% |
Q4 2016 | $316,000 | -10.2% | 25,080 | +99.8% | 0.01% | -10.0% |
Q3 2016 | $352,000 | -7.9% | 12,550 | +15.0% | 0.01% | -16.7% |
Q2 2016 | $382,000 | – | 10,910 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SENZAR ASSET MANAGEMENT, LLC | 445,200 | $7,101,000 | 1.80% |
Redmile Group, LLC | 1,254,342 | $20,007,000 | 1.30% |
Irving Magee Investment Management | 166,505 | $2,656,000 | 1.02% |
BROADVIEW ADVISORS LLC | 376,050 | $5,998,000 | 0.83% |
Sivik Global Healthcare LLC | 101,000 | $1,611,000 | 0.75% |
FRONTIER CAPITAL MANAGEMENT CO LLC | 5,455,461 | $87,015,000 | 0.64% |
Iguana Healthcare Management, LLC | 75,000 | $1,196,000 | 0.59% |
RIVERBRIDGE PARTNERS LLC | 1,464,286 | $23,355,000 | 0.47% |
HERMES INVESTMENT MANAGEMENT LTD | 1,772,777 | $28,276,000 | 0.46% |
Endurant Capital Management LP | 85,043 | $1,356,000 | 0.44% |